Opportunity
Alaska Online Public Notices #225595
Alaska Pharmacy and Therapeutics Committee Meeting on the Preferred Drug List
Posted
October 20, 2026
Identifier
225595
The State of Alaska is convening a public committee meeting to review its Preferred Drug List. - Government buyer: State of Alaska, Department of Health, Division of Health Care Services. - Opportunity type: Public Pharmacy and Therapeutics Committee meeting; the notice does not announce a procurement or award. - Topics: Drug classes related to cystic fibrosis, the central nervous system, analgesics, and substance dependence. - Participation: Pharmaceutical manufacturers may submit unsolicited materials related to agenda items and give brief presentations during relevant class discussions. Public members and health care professionals may also submit materials and provide comments. - Meeting format: Remote webinar and teleconference. - OEMs and vendors: None identified by name. No products, services, quantities, or part numbers are requested.
Description
The State of Alaska Department of Health, Division of Health Care Services, will sponsor a Pharmacy and Therapeutics Committee meeting to address the Preferred Drug List. The meeting is scheduled for November 20, 2026, and will be held via Teams webinar with teleconference dial-in available. Pharmaceutical manufacturers may submit material related to agenda items by November 6, 2026, and members of the public may submit material by November 18, 2026. The notice also describes public comment procedures, written comment options, and accessibility accommodations.